Epstein Secrets

titled "Responses to Arguments from JE Counsel" containing: ■ 7/13/2007 letter from Lilly Ann Sanchez to Andrew Lourie with handwritten attorney (Lourie) notes; ■ 6/25/2007 letter from Gerald Lefcourt to Jeffrey Sloman, Matt Menchal, Andrew Lourie, and Marie Villaftuia with handwritten attorne

ps taken to obtain DOJ authorization Work Product 6(e) Deliberative Process Investigative Privilege 2 5/21/2007 email from Marie Villafafta to Myesha Braden (CEOS) re 2423(b) charging question Work Product 6(e) Deliberative Process Investigative Privilege 3 5/21/2007 email from Marie Villafafia to

so the plea agreement would have had to be a binding plea pursuant to Fed. R. Crim. P. 11(c)(1)(C), which is what I drafted. I was informed by Mr. Lourie that USA Acosta did not want to do a (c)(1)(C) plea, so I had to find charges that would result in a two-year statutory maximum. This resulted in m

stein's team was equally successful in DC, where they dictated who could and could not participate in the "independent review" at CEOS. For example, Myesha Braden, who had not yet joined the Leap Year team, was excluded from consideration because she had disagreed with Lilly Ann Sanchez about the handling of

pre-indictment consultation contract Work Product 6(e) Investigative Privilege P-013977 thru P-013979 5/21/2007 email from Marie Villafaba to Myesha Braden (CEOS) re 2423(b) charging question Work Product 6(e) Deliberative Process Investi ative Privile e P-013980 5/21/2007 email from Marie Villafa

k Product Deliberative Process Investigative Privilege P-014026 thru P-014027 7/16/2007 email from Marie Villafafia to Matt Menchel and Andrew Lourie regarding correspondence from Roy Black and Motion to Quash 6(e) Work Product Deliberative Process Investigative Privilege P-014028 thru P-014